THERAMetrics announces a Notice of registration for its Trademark THERAMetrics from the World Intellectual Property Organization

Stans, Switzerland, March 17, 2014 - THERAMetrics holding AG (the “Company” - SIX: TMX) today announces the Notice of allowance and registration for its Trademark “THERAMetrics” from the World Intellectual Property Organization for the use in the USA and European Union. A trademark is a sign capable of distinguishing the goods or services of one enterprise from those of other enterprises. Trademarks are protected by intellectual property rights. The registered trademark “THERAMetrics” is valid at least until the year 2023 in the International Classes 05, and 42. International Class 42 comprises: Scientific research to order; conducting of research and development in the medical, pharmaceutical, pharmacological, biochemical and/or medical technology fields for others; conducting to order clinical studies and tests; assessment to order of scientific projects, evaluation to order of clinical studies and experiments; providing technical know-how; providing scientific cooperations; conducting scientific projects in the medical, pharmaceutical, pharmacological, biochemical, and/or medical technology fields for others; scientific analysis laboratories. International Class 05 comprises: Pharmaceutical and veterinary preparations, medicines as well as chemicals for sanitary purposes for medicine; pharmaceutical products; pharmaceutical products for rare diseases; chemicals intended for healing, health care or medical and veterinary purposes; dietetic substances for medical use, health care and medical or veterinary purposes; disinfectants; products for destroying vermin; fungicides; herbicides; chemicals for medical sciences (for use in or on the human and/or animal body), diagnostic products for medical purposes; radiological contrast substances for medical purposes, detergents for medical purposes, diagnostic products for medical purposes, medical products for the mouth and the skin. About THERAMetrics THERAMetrics holding AG is a tech-based Contract Research & Development Organisation dedicated to provide a full range of technological solutions through the entire value chain of drug discovery and development. The company, listed at the SIX Swiss Exchange (TMX) and located in Stans (Switzerland). For further information please contact: THERAMetrics holding AG Investor and External Relations Tel.: +41 79 285 37 81 [email protected] www.therametrics.com Disclaimer This communication expressly or implicitly contains certain forward-looking statements concerning THERAMetrics holding AG and its business. Such statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of THERAMetrics holding AG to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. THERAMetrics holding AG is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.

Suggested Articles

Genesis Drug Discovery & Development has bought up New England Discovery Partners as it looks to boost its synthetic and medicinal chemistry.

Sanofi plans to incorporate its real-world data platform with Aetion’s analytics system to better develop studies for regulatory decision-making.

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.